Geneticure

company

About

Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.68M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Medical,Personal Health,Pharmaceutical
Founded date
Oct 22, 2016
Number Of Employee
1 - 10
Operating Status
Active

Geneticure is a Mayo Clinic backed company that has created a patented cheek-swab test that can predict individual treatment response for high blood pressure medications and devices therapies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$5.96M
Geneticure has raised a total of $5.96M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2022 Seed $1.68M Detail
Dec 31, 2019 Seed $1M Detail
Apr 1, 2018 Seed $1.36M 1 Detail
Sep 1, 2017 Seed $850K 1 Wireframe Ventures Detail
Apr 5, 2017 Seed $200K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Geneticure is funded by 4 investors. Wireframe Ventures and Fairview Health Services are the most recent investors.
Investor Name Lead Investor Funding Round
Wireframe Ventures Yes Seed
Fairview Health Services Yes Pre-seed
Mayo Clinic Ventures Seed
M25 Seed

Employee Profiles

Number of Employee Profiles
3
Geneticure has 3 current employee profiles, including Executive Eric Snyder
Executive
Executive
Executive